<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CD017B8A-A0A5-4BB0-A145-4AE58D8D2A3D"><gtr:id>CD017B8A-A0A5-4BB0-A145-4AE58D8D2A3D</gtr:id><gtr:name>Audition Therapeutics Limited</gtr:name><gtr:address><gtr:line1>COLLEGE OF SCIENCE &amp; TECHNOLOGY CLIFTON CAMPUS , CLIFTON</gtr:line1><gtr:city>NOTTINGHAM</gtr:city><gtr:postCode>NG11 8NS</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD017B8A-A0A5-4BB0-A145-4AE58D8D2A3D" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>CD017B8A-A0A5-4BB0-A145-4AE58D8D2A3D</gtr:id><gtr:name>Audition Therapeutics Limited</gtr:name><gtr:address><gtr:line1>COLLEGE OF SCIENCE &amp; TECHNOLOGY CLIFTON CAMPUS , CLIFTON</gtr:line1><gtr:city>NOTTINGHAM</gtr:city><gtr:postCode>NG11 8NS</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>24875.0</gtr:offerGrant><gtr:projectCost>41459.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A9D51031-BA48-4766-91A3-4834FC5D7FA6"><gtr:id>A9D51031-BA48-4766-91A3-4834FC5D7FA6</gtr:id><gtr:firstName>Graeme</gtr:firstName><gtr:surname>Wilkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=700629"><gtr:id>EC09C6CE-7152-4733-9B15-2B95914F7EC3</gtr:id><gtr:title>Solid State Micro-Needle Array for the Treatment of Chronic Otitis Media with Effusion</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>GRD Proof of Market</gtr:grantCategory><gtr:grantReference>700629</gtr:grantReference><gtr:abstractText>Chronic otitis media with effusion (COME), the inflammation and accumulation of fluid
within the middle ear, is the most common cause of hearing impairment in children between
the ages of 2 and 6; potentially causing language delays, learning difficulties and behavioural
problems. In persistent cases it is primarily resolved by a surgical procedure that involves the
insertion of a grommet, necessitating an ENT surgeon, and a general anaesthetic. Audition
Therapeutics Ltd has developed an aeration device that will be accessible to a wider range of
children at the onset of COME, alleviate the costs and replace this need for grommet insertion
and general anaesthesia</gtr:abstractText><gtr:fund><gtr:end>2016-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>24875</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">700629</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>